To use our test, clinicians will only have to collect 2 drops of blood obtained via a prick to the patient’s finger. This will be enough for the test to detect the biomarker levels in less than 20 min and display the results as an intuitive color-coded risk category: red for those at high risk, yellow for those at moderate risk, green for those at low risk. Based on these categories, clinicians can then decide whether to admit the patient to the hospital for treatment, keep them for observation, or discharge them. For the final version of our test, we plan to incorporate the results of our test into a mobile application that will display the results along with important information about the newborn, such as weight, age, vital signs, that will help the clinician make the best decision.